Directors
Chris Mirabelli, (Chairman) Health Care Ventures
Denis Lucquin, Sofinnova Partners
Edward Connor, M.D., MedImmune Ventures
Dave Summa, Acumen Pharmaceuticals
Julie Eskay-Eagle, Wellcome Trust
Steven Skolsky, Sequoia Pharmaceuticals
John Erickson, Sequoia Pharmaceuticals
Julie Eskay-Eagle , The Wellcome Trust
Ms. Eskay-Eagle manages September Ventures, and previously was a full-time employee of The Wellcome Trust in London, UK from 2001-2004 where she established a formal Direct Investment Program. Prior to joining the Trust she was a Vice President with Lazard Freres in Health Care Investment Banking and a founding member of Lazard Technology Partners. Before joining Lazard, she was a Health Care Specialist with McKinsey & Co. in New York. Ms. Eskay-Eagle has a bachelor’s degree in Biomedical Ethics from Cornell University and an MBA from Columbia University.